Company Overview of ApopLogic Pharmaceuticals LLC
ApopLogic Pharmaceuticals LLC, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products that target apoptotic cell death pathways. It offers Brecept for cancers; Cytonil to treat Sezary leukemia, cutaneous T cell lymphoma, and psoriasis; and Fasaret, a therapy for the treatment of cancers. The company was founded in 2006 and is based in Aurora, Colorado.
12635 East Montview Boulevard
Aurora, CO 80010
Founded in 2006
Key Executives for ApopLogic Pharmaceuticals LLC
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ApopLogic Pharmaceuticals LLC, please visit apoplogic.com/index.html. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.